Each vial contains 200 µg of lyophilized peptide derived from the human EP1 receptor sequence (C-terminal amino acids 380-402; GLTPSAWEASSLRSSRHSGLSHF.1 This peptide was used as an antigen for production of Cayman’s EP1 receptor polyclonal antibody (Catalog No. 101740) and can be used in conjunction with this antibody to block protein-antibody complex formation during analysis for the EP1 receptor.
1
Funk, C.D., Furci, L., Fitzgerald, G.A., et al. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 268 26767-26772 (1993).
Coleman, R.A., Smith, W.L., and Narumiya, S. Classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46 205-229 (1994).
Funk, C.D., Furci, L., Fitzgerald, G.A., et al. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 268 26767-26772 (1993).
Breyer, M.D., Davis, L., Jacobson, H.R., et al. Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol 270 F912-F918 (1996).
Southall, M.D., and Vasko, M.R. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276(19) 16083-16091 (2001).
Coleman, R.A., Eglen, R.M., Jones, R.L., et al. Classification of prostanoid receptors IUPHAR receptor compendium. IUPHAR Compendium 1-12 (1997).
Show all 5
Hide all but first 3